BACKGROUND: Osteogenic protein-1 (OP-1, BMP-7) induces bone formation and cartilage growth. Since OP-1 is an anabolic factor expressed by human articular chondrocytes, we examined the response of endogenous OP-1 to interleukin-1beta (IL-1beta) in human articular cartilage. METHODS: Normal adult human articular cartilage explants were cultured for twenty-five days in the presence of medium only or were treated with a low dose (0.1 ng/mL) or high dose (1.0 ng/mL) of IL-1beta for forty-eight or ninety-six hours. Alternately, cartilage explants were cultured forty-eight hours with IL-1beta, followed by forty-eight hours in standard medium (recovery). Tissue was analyzed for OP-1 message (by means of the reverse transcriptase-polymerase chain reaction), protein (by means of enzyme-linked immunosorbent assay and Western blot analysis) and proteoglycan content. Medium was analyzed for released proteoglycans and OP-1. RESULTS: In the presence of medium, OP-1 maintained its steady state of mRNA and protein expression for as long as twenty-five days in culture. A low dose of IL-1beta led to some upregulation in message and a twofold (p < 0.02) increase in OP-1 protein characterized by enhanced processing and activation of OP-1. Removal of IL-1beta (recovery experiments) did not reverse its effect on OP-1 synthesis. A high dose of IL-1beta caused stronger upregulation of message and a twofold decrease in OP-1 protein content (p < 0.007) in the cartilage matrix. However, this decrease in the matrix was primarily due to a release of active OP-1 into the medium. After removal of the 1.0-ng/mL IL-1beta, the levels of OP-1 protein did not recover. CONCLUSION: The results of the present study indicate that human adult chondrocytes have an ability to respond anabolically to initial or early catabolic events through an upregulation of endogenous OP-1.
BACKGROUND:Osteogenic protein-1 (OP-1, BMP-7) induces bone formation and cartilage growth. Since OP-1 is an anabolic factor expressed by human articular chondrocytes, we examined the response of endogenous OP-1 to interleukin-1beta (IL-1beta) in humanarticular cartilage. METHODS: Normal adult humanarticular cartilage explants were cultured for twenty-five days in the presence of medium only or were treated with a low dose (0.1 ng/mL) or high dose (1.0 ng/mL) of IL-1beta for forty-eight or ninety-six hours. Alternately, cartilage explants were cultured forty-eight hours with IL-1beta, followed by forty-eight hours in standard medium (recovery). Tissue was analyzed for OP-1 message (by means of the reverse transcriptase-polymerase chain reaction), protein (by means of enzyme-linked immunosorbent assay and Western blot analysis) and proteoglycan content. Medium was analyzed for released proteoglycans and OP-1. RESULTS: In the presence of medium, OP-1 maintained its steady state of mRNA and protein expression for as long as twenty-five days in culture. A low dose of IL-1beta led to some upregulation in message and a twofold (p < 0.02) increase in OP-1 protein characterized by enhanced processing and activation of OP-1. Removal of IL-1beta (recovery experiments) did not reverse its effect on OP-1 synthesis. A high dose of IL-1beta caused stronger upregulation of message and a twofold decrease in OP-1 protein content (p < 0.007) in the cartilage matrix. However, this decrease in the matrix was primarily due to a release of active OP-1 into the medium. After removal of the 1.0-ng/mL IL-1beta, the levels of OP-1 protein did not recover. CONCLUSION: The results of the present study indicate that human adult chondrocytes have an ability to respond anabolically to initial or early catabolic events through an upregulation of endogenous OP-1.
Authors: Tania Silvestri; Lia Pulsatelli; Paolo Dolzani; Luigi Frizziero; Andrea Facchini; Riccardo Meliconi Journal: Rheumatol Int Date: 2005-03-16 Impact factor: 2.631
Authors: Susanna Chubinskaya; Eric J Cotter; Rachel M Frank; Arnavaz A Hakimiyan; Adam B Yanke; Brian J Cole Journal: Cartilage Date: 2019-05-14 Impact factor: 4.634
Authors: Susan Chubinskaya; Lori Otten; Stephan Soeder; Jeffrey A Borgia; Thomas Aigner; David C Rueger; Richard F Loeser Journal: Arthritis Res Ther Date: 2011-03-29 Impact factor: 5.156
Authors: Susan Chubinskaya; Benjamin S Frank; Margaret Michalska; Bhavna Kumar; Charis A Merrihew; Eugene J-M A Thonar; Mary Ellen Lenz; Lori Otten; David C Rueger; Joel A Block Journal: Arthritis Res Ther Date: 2006-04-28 Impact factor: 5.156
Authors: Kolja Gelse; David Pfander; Simon Obier; Karl X Knaup; Michael Wiesener; Friedrich F Hennig; Bernd Swoboda Journal: Arthritis Res Ther Date: 2008-09-12 Impact factor: 5.156